Lannett Company Inc. is recalling 8,544 bottles of Lisdexamfetamine Dimesylate Capsules, 40 mg (the generic equivalent of Vyvanse). The recall was issued because bottles labeled as containing 40 mg capsules actually contained 30 mg capsules. Consumers should check their 100-count bottles for specific lot numbers and expiration dates to ensure they are receiving the correct dosage. If you have this medication, contact your healthcare provider or pharmacist regarding the dosage discrepancy.
Patients may receive a lower dose of medication than prescribed (30 mg instead of 40 mg), which could result in inadequate treatment and the return of symptoms for their underlying condition. No incidents or injuries have been reported to date.
You have 2 options:
A bottle labeled as 40mg contained 30mg capsules.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.